efmoroctocog alfa

Italy

Drugs containing this active substance

  • ELOCTA

    It is used for the treatment and prevention of bleeding in patients of all ages with hemophilia A, a hereditary disease caused by a deficiency of factor VIII.

    Form: solution for injection, powder and solvent

    Active substance Dosage
    efmoroctocog alfa -

    ATC: B02BD02

    Manufacturer: SWEDISH ORPHAN BIOVITRUM AB (PUBL)